Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» November 2010
November 2010
Virgin Market for New Bone Marrow Cancer Drug
Virgin Market for New Bone Marrow Cancer Drug
Minyanville
Incyte
myelofibrosis
YM BioSciences
CYT387
ONYX Pharmaceuticals
Sanofi leads drug stocks south
Sanofi leads drug stocks south
MarketWatch
Sanofi
Genzyme open to Campath clause in Sanofi bid: report
Genzyme open to Campath clause in Sanofi bid: report
Yahoo/Reuters
Genzyme
Sanofi
M&A
Genzyme Lists Poison Pills, Talks to Other Companies, Termeer Tells Figaro
Genzyme Lists Poison Pills, Talks to Other Companies, Termeer Tells Figaro
Bloomberg
M&A
Genzyme
Sanofi
Sanofi Buyout Target Genzyme Meets First Deadline on Manufacturing Changes
Sanofi Buyout Target Genzyme Meets First Deadline on Manufacturing Changes
Bloomberg
M&A
Genzyme
Sanofi
Is Merck the Perfect Stock?
Is Merck the Perfect Stock?
Motley Fool
Merck
Twin blows spur a crisis of confidence in RNAi
Twin blows spur a crisis of confidence in RNAi
Fierce Biotech
RNAi
Roche
Alnylam
Patience With Bristol-Myers Squibb
Patience With Bristol-Myers Squibb
Traders Huddle
Bristol-Myers Squibb
'Record' drug shortages include cancer meds
'Record' drug shortages include cancer meds
Fierce Pharma
drug shortages
Ligand Pharma says Roche terminates agreement
Ligand Pharma says Roche terminates agreement
Reuters
Roche
Ligand
hepatitis C
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »